Why the study?
Does Vitamin E or pioglitazone improve outcomes in adults without diabetes with nonalcoholic steatohepatitis?
Does Vitamin E or pioglitazone improve outcomes in adults without diabetes with nonalcoholic steatohepatitis?
Answers are grounded in this paper and cite their sources.
Vitamin E is superior to placebo for treating nonalcoholic steatohepatitis in adults without diabetes, whereas pioglitazone does not significantly improve the primary outcome.
Vitamin E was superior to placebo for the treatment of nonalcoholic steatohepatitis in adults without diabetes. There was no benefit of pioglitazone over placebo for the primary outcome; however, significant benefits of pioglitazone were observed for some of the secondary outcomes. (ClinicalTrials.gov number, NCT00063622.)
No takes yet. Share an insight, caveat, or question.
Sanyal et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: